Company Data
Terns Pharmaceuticals Inc.
Ticker
TERN
Current Price
$6.96 -1.56%
Market Cap
$609.1M
Price Target
Refer to Report
Volume
911.9K
52wk Range
$1.865 - $11.4
Overview
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.